About Vensica Medical
Vensica Medical is a company based in Tel Aviv (Israel) founded in 2014. Vensica Medical has raised $32.5 million across 4 funding rounds from investors including The Trendlines Group, Laborie Medical and Cogentix Medical. Vensica Medical offers products and services including Vibe and ViXe. Vensica Medical operates in a competitive market with competitors including Taris Biomedical and Alessa Therapeutics, among others.
- Headquarter Tel Aviv, Israel
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$32.5 M (USD)
in 4 rounds
-
Latest Funding Round
$11 M (USD), Series B
Nov 18, 2024
-
Investors
The Trendlines Group
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vensica Medical
Vensica Medical offers a comprehensive portfolio of products and services, including Vibe and ViXe.
Needle-free ultrasound platform for targeted drug delivery in urology.
Combines neurotoxin with ultrasound for bladder wall treatments.
People of Vensica Medical
Unlock access to complete
Unlock access to complete
Funding Insights of Vensica Medical
Vensica Medical has successfully raised a total of $32.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vensica Medical
Vensica Medical has secured backing from 7 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include The Trendlines Group, Laborie Medical and Cogentix Medical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund and startup incubator for healthcare and agricultural companies
|
Locked | Locked | Locked | |
|
Merz is recognized as a leader in aesthetic medicine and neurotoxin therapy.
|
Locked | Locked | Locked |
Investor details for Vensica Medical
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vensica Medical
Investment portfolio details for Vensica Medical
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vensica Medical
Detailed financials for Vensica Medical
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vensica Medical Comparisons
Peer comparison for Vensica Medical
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vensica Medical
Vensica Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Taris Biomedical and Alessa Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug delivery technology for genitourinary diseases is developed.
|
|
| Locked | Locked | Locked |
Sustained drug delivery implants for prostate tumors are developed.
|
Detailed competitors of Vensica Medical
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vensica Medical
Complete news archive for Vensica Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vensica Medical
Vensica Medical was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Vensica Medical is headquartered in Tel Aviv, Israel.
Vensica Medical is a funded company, having raised a total of $32.5M across 4 funding rounds to date.
Vensica Medical was founded in 2014 in Tel Aviv, Israel, within the medical device sector focused on urology. Drug delivery catheters are developed for bladder conditions, with the VensiCare device enabling ultrasound application to the bladder prior to drug instillation. Operations center on innovative solutions for targeted therapies, serving healthcare needs in noninvasive treatments.
Vensica Medical's top competitors include Alessa Therapeutics and Taris Biomedical.
Vensica Medical offers Vibe and ViXe.
Vensica Medical has 7 investors. Key investors include The Trendlines Group, Laborie Medical, Cogentix Medical, Israel Biotech Fund, and Merz.